Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Terumo prepares inhibitors of smooth muscle cell proliferation

March 25, 1997

Santen characterizes dual NEP/ACE inhibitor

March 24, 1997

Glaxo Wellcome discloses cGMP-PDE inhibitors

March 24, 1997

Diovan introduced in U.S.

March 21, 1997

Cell migration inhibitors from Teijin

March 21, 1997

Gensia Sicor selects Brevibloc distributor for U.K. and Ireland

March 20, 1997

Promising PHP phase I/II results reported

March 20, 1997

International sepsis forum established with funding from Bayer

March 20, 1997

SA-7060: a dual NEP and ACE inhibitor from Santen

March 20, 1997

Sumitomo presents new Na+/H+-exchange inhibitor

March 20, 1997

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...